Rydex Biotechnology Fund Class A (RYBOX)
| Fund Assets | 136.15M |
| Expense Ratio | 1.65% |
| Min. Investment | $2,500 |
| Turnover | 79.00% |
| Dividend (ttm) | 9.41 |
| Dividend Yield | 14.11% |
| Dividend Growth | -0.18% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 16, 2025 |
| Previous Close | 66.08 |
| YTD Return | -2.04% |
| 1-Year Return | 22.17% |
| 5-Year Return | 2.64% |
| 52-Week Low | 43.17 |
| 52-Week High | 68.01 |
| Beta (5Y) | n/a |
| Holdings | 77 |
| Inception Date | Sep 1, 2004 |
About RYBOX
Rydex Biotechnology Fund Class A is a mutual fund designed to provide investors with targeted exposure to the biotechnology sector. Its primary purpose is capital appreciation by investing at least 80% of its net assets in equity securities of biotechnology companies, including firms engaged in research, development, manufacturing, and marketing of products and services based on advanced biological processes. The fund is team-managed and seeks to minimize single stock risk through diversified holdings across industry leaders and emerging innovators. Notable portfolio positions include prominent biotechnology companies such as Gilead Sciences, Regeneron Pharmaceuticals, and Alnylam Pharmaceuticals. By focusing on this sector, the fund plays a significant role for investors seeking access to the growth potential and scientific advancements within biotechnology—an industry that impacts healthcare, pharmaceuticals, agriculture, and related fields. The fund’s structure, with a relatively high expense ratio and an annual distribution schedule, caters to investors who are interested in specialized sector exposure rather than broad market diversification.
Performance
RYBOX had a total return of 22.17% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.95%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FIKCX | Fidelity | Fidelity Advisor Health Care Fund - Class Z | 0.59% |
| FSPHX | Fidelity | Fidelity Select Health Care Portfolio | 0.63% |
| FIJYX | Fidelity | Fidelity Advisor Biotechnology Fund - Class Z | 0.61% |
| FACDX | Fidelity | Fidelity Advisor Health Care Fund - Class A | 0.98% |
| FSHCX | Fidelity | Fidelity Select Health Care Services Portfolio | 0.67% |
Top 10 Holdings
36.83% of assets| Name | Symbol | Weight |
|---|---|---|
| AbbVie Inc. | ABBV | 7.53% |
| Amgen Inc. | AMGN | 4.96% |
| Gilead Sciences, Inc. | GILD | 4.49% |
| Vertex Pharmaceuticals Incorporated | VRTX | 4.41% |
| Regeneron Pharmaceuticals, Inc. | REGN | 3.65% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.90% |
| Insmed Incorporated | INSM | 2.32% |
| Natera, Inc. | NTRA | 2.27% |
| AstraZeneca PLC | AZN | 2.22% |
| Biogen Inc. | BIIB | 2.09% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $9.40578 | Dec 16, 2025 |
| Dec 12, 2024 | $9.42277 | Dec 12, 2024 |
| Dec 20, 2022 | $0.89943 | Dec 20, 2022 |
| Dec 8, 2021 | $15.77303 | Dec 8, 2021 |
| Dec 9, 2020 | $6.95038 | Dec 9, 2020 |
| Dec 10, 2019 | $3.60206 | Dec 10, 2019 |